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Several investigators (1-4) have now unequivocally docu-
mented that myocardial ischemia and angina can occur in
patients with normal epicardial coronary arteries as the result
of inadequate vasodilator reserve or of actual constriction
of the small intramural coronary arteries. The precise site
of this abnormally elevated resistance is usually assumed
or implied to reside in the coronary arterioles, whose pri-
mary function is to actively constrict and dilate while serving
their role in autoregulation. The autoregulatory mechanisms
closely couple myocardial oxygen supply with myocardial
oxygen demand, a function so basic to survival that it in-
tuitively seems to us unlikely that the abnormality in vaso-
dilator reserve resides in these vessels.
In this regard, Chilian et al. (5) demonstrated by micro-
puncture techniques that the pre-arteriolar arteries of the 100
to 250 /.L range contribute approximately 25% of resistance
to coronary flow in the beating normal cat heart and Till-
manns et al. (6), using fluorescence microscopy, found that
ergometrine constricted the microvascular pre-arteriolar ves-
sels, but not the terminal arterioles of beating rat and cat
hearts. Moreover, in patients dying with hypertrophic car-
diomyopathy, we and others (7-9) have found intimal and
medial abnormalities of the intramural (approximately 100
to 500 /.L) pre-arteriolar coronary arteries that often narrow
the vessel lumen (7,8), and that may be responsible for
myocardial ischemia in these patients (7,9). Hence, al-
though the abnormal resistance to flow that is present in
patients with angina and normal epicardial coronary arteries
may reside in the arterioles, our attention focused on the
possibility that the impediment to flow may be located in
the small intramural pre-arteriolar vessels.
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The concept of ischemia due to increased resistance
in the pre-arteriolar versus arteriolar coronary vessels.
With currently available methods, it is impossible to deter-
mine which of these two sites serves to impede flow in
humans. However, we have developed a theoretical con-
cept, based on recent observations we have made, that may
provide insight relating to this issue. We demonstrated (10)
that when dipyridamole (0.5 to 0.75 mg/kg body weight)
was administered intravenously to patients with angina and
normal epicardial coronary arteries, transmural flow to the
anterior left ventricle increased by an average of 113%, but
the increase was accompanied by the precipitation of severe
chest pain in 18 of 25 subjects. If, as we believe, the chest
pain was due to myocardial ischemia, the question arises
as to how angina develops in the presence of increased
transmural flow. The probable answer to this apparent par-
adox suggests to us that the site of abnormally increased
resistance in these patients lies not in the arterioles, but in
the pre-arteriolar small coronary vessels. The reasons fa-
voring this concept follow.
Figure IA depicts the situation that would exist if the
abnormal vasodilator reserve was due to a basic abnormality
of the arterioles. Because most patients appear to have mild
ischemia, and many demonstrate regional functional ab-
normalities (2,3, II), it is likely that the abnormality is het-
erogeneous, rather than involving all of the arterioles sup-
plying the myocardium. The specific group of arterioles that
is abnormal is not important to the development of this
concept. In this example, we have arbitrarily assumed that
the arterioles supplying the subendocardium are the vessels
with abnormal vasodilator reserve, and that the subepicar-
dial vessels are normal. When dipyridamole, a potent ar-
teriolar dilator, is administered, the normally responsive
subepicardial arterioles (Rd will dilate maximally, whereas
the abnormal subendocardial arterioles (Rz) will dilate little,
if at all. Hence, flow will increase to the subepicardial region
and remain unchanged or increase only slightly in the sub-
endocardial region. Given this model, it appears impossible
to conceive of a situation in which myocardial ischemia
would be precipitated.
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Figure 2. The influence of increasing coronary flow on the pres-
sure drop (AP, in %) acrossa stenosis. The differentcurvesdenote
the changing relation with different degrees of luminal narrowing
(rnrrr'). (Modified by permission of the American Heart Associ-
ation, Inc. from Klocke F [19].)
creases in a curvilinear fashion with increasing flow, and
the steepness of the curve is related to the severity of the
stenosis. Figure 2 is derived from estimates of drops in
pressure across stenoses of the large epicardial vessels, but
the concepts can be applied conceptually to narrowings that
may be present in smaller intramural vessels. Thus, an in-
crease in flow across a narrowed small intramyocardial ar-
tery would cause viscous and turbulent energy losses, as
has been theorized to occur across epicardial obstructive
lesions (12-18), and this would result in a fall in perfusion
pressure distally (P z in Fig. IB).
Consequences of increased pressure drop across a fixed
stenosis with increased flow. The increased pressure drop
across a fixed stenosis that develops with increased flow has
important consequences. Dipyridamole, by increasing flow
in the model depicted in Figure IB, increases the pressure
drop across the narrowing, and thereby lowers the driving
pressure responsible for perfusing the subepicardial and sub-
endocardial vessels. The dipyridamole-induced decrease in
subepicardial vessel resistance (R 1) permits subepicardial
flow to increase, but because subendocardial vessel resis-
tance (Rz) does not fall, the decreased driving pressure causes
subendocardial flow to fall, with resulting ischemia. This
model of the site of obstruction therefore provides a mech-
anism by which a decrease in flow perfusing one region of
myocardium can occur despite a concomitant increase in
transmural flow. In essence, this is the pathophysiology of
a "subendocardial steal," in which the coronary obstruction
is not located in the epicardial vessel, but in small vessels
proximal to the arterioles.
Summary. It is not possible at this time to definitively
determine the precise mechanisms responsible for the in-
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Figure 1. Two modelsof increasedcoronaryresistance andnormal
epicardial coronary arteries. A, The abnormal resistance to flow
(R2) , which could be either a fixed anatomicor a functional defect,
is depicted as lying at the arteriolar level. B, The intramural, pre-
arteriolar, small coronary arteries are the site of the increased
resistance to flow (R3) . PI and Pz = the pressures proximal and
distal to the abnormal resistance, respectively; R1 = the normally
responsive subepicardial arterioles.
In contrast, Figure 1B depicts the situation in which the
flow-impeding resistance is located in the intramural but
pre-arteriolar coronary arteries. Because the myocardial ox-
ygen demands of the subendocardium are normally greater
than those of the subepicardium, the subendocardial resis-
tance vessels (R z) are more dilated than those of the sub-
epicardium (R,). In this situation, a vasodilator stimulus
will decrease subepicardial resistance (R I) but will not alter
subendocardial resistance (Rz), because its vasodilator re-
serve is already exhausted. This will result in a net decrease
in transmural resistance, and therefore an increase in flow.
Relation between coronary flow and pressure drop
across a stenosis. Two basic hydrodynamic principles of
stenotic lesions are 1) that a pressure drop develops across
the stenosis because of energy losses incurred when blood
crosses through the narrowing, and 2) that the magnitude
of the pressure drop is related to the magnitude of flow in
an exponential manner (12-18). This is depicted in Figure
2, which demonstrates the relation between a pressure drop
across a stenosis and coronary flow: the pressure drop in-
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adequate vasodilator reserve experienced by patients with
angina pectoris and normal epicardial coronary arteries.
However, the concepts we have developed suggest that the
results derived from an agent having the capacity to mark-
edly dilate arterioles might indicate whether the site of ab-
normal resistance lies at the arterioiar or the pre-arteriolar
small vessel level. Although models other than the two we
have presented might ultimately be derived and be found to
provide alternative explanations as to the precise site of
abnormal resistance, our current speculations suggest that
additional attention should be focused on the small intra-
myocardial pre-arteriolar vessels as a site that can limit flow
and thereby contribute to the precipitation of myocardial
ischemia.
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